Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 20 9 2024
Statut: ppublish

Résumé

Between January and August 2024, mpox cases have been reported in nearly all provinces of the Democratic Republic of the Congo (DRC). Monkeypox virus genome sequences were obtained from 11 mpox cases' samples, collected in July-August 2024 in several health zones of Kinshasa. Characterisation of the sequences showed subclades Ia and Ib co-circulating in the Limete health zone, while phylogenetic analyses suggested multiple introductions of the two subclades in Kinshasa. This illustrates the growing complexity of Clade I mpox outbreaks in DRC.

Identifiants

pubmed: 39301745
doi: 10.2807/1560-7917.ES.2024.29.38.2400592
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Tony Wawina-Bokalanga (T)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Prince Akil-Bandali (P)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Eddy Kinganda-Lusamaki (E)

TransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.
Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Emmanuel Lokilo (E)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Daan Jansen (D)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Adrienne Amuri-Aziza (A)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Jean-Claude Makangara-Cigolo (JC)

Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Elisabeth Pukuta-Simbu (E)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Rilia Ola-Mpumbe (R)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Mamito Muyembe (M)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Cris Kacita (C)

Institut National de Santé Publique (INSP), Kinshasa, Democratic Republic of the Congo.

Princesse Paku-Tshambu (P)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Pedro Hlf Dantas (PH)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Olivier Tshiani-Mbaya (O)

Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Gradi Luakanda (G)

Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Antoine Nkuba-Ndaye (A)

Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Meris Matondo (M)

Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Emmanuel Hasivirwe Vakaniaki (EH)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Sofonias Tessema (S)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Nicaise Ndembi (N)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Áine O'Toole (Á)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, United Kingdom.

Tessa De Block (T)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Christian Ngandu (C)

Institut National de Santé Publique (INSP), Kinshasa, Democratic Republic of the Congo.

Nicole A Hoff (NA)

Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, United States.

Nicola Low (N)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Lorenzo Subissi (L)

World Health Organization, Geneva, Switzerland.

Sydney Merritt (S)

Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, United States.

Jean-Jacques Muyembe-Tamfum (JJ)

Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Laurens Liesenborghs (L)

Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Martine Peeters (M)

TransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.

Eric Delaporte (E)

TransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.

Jason Kindrachuk (J)

Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Anne W Rimoin (AW)

Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, United States.

Steve Ahuka-Mundeke (S)

Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Andrew Rambaut (A)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, United Kingdom.

Dieudonné Mwamba (D)

Institut National de Santé Publique (INSP), Kinshasa, Democratic Republic of the Congo.

Koen Vercauteren (K)

These authors contributed equally to this work and share last authorship.
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Placide Mbala-Kingebeni (P)

These authors contributed equally to this work and share last authorship.
Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH